ACAD
38.15
-0.08
-0.21%
AEMD
0.19
0.00
-2.31%
APRI
2.41
-0.12
-4.75%
ARNA
4.08
-0.2
-4.67%
ATEC
1.52
+0.02
+1.33%
CFN
60.09
-0.11
-0.18%
CNAT
6.35
+0.15
+2.42%
CRXM
0.2
-0.01
-6.62%
CYTX
1.18
+0.06
+5.27%
DXCM
58.98
-0.68
-1.14%
GNMK
12.72
-0.26
-2.00%
HALO
15.22
0.00
0.00%
ILMN
195.97
+1.91
+0.98%
INNV
0.19
+0.02
+8.89%
INO
7.06
-0.11
-1.53%
ISCO
0.06
0.00
-2.11%
ISIS
68.5
+1.7
+2.54%
LGND
66.69
+3.11
+4.89%
LPTN
2.95
+0.01
+0.34%
MBVX
0.93
+0.03
+3.33%
MEIP
5.7
+0.04
+0.71%
MNOV
3.63
+0.09
+2.54%
MRTX
23.66
-0.53
-2.19%
MSTX
0.52
-0.01
-0.96%
NBIX
40.65
+0.22
+0.54%
NUVA
44.21
-0.46
-1.03%
ONCS
0.37
+0.01
+3.04%
ONVO
5.74
-0.01
-0.17%
OREX
7.73
+1.94
+33.44%
OTIC
36.62
+0.24
+0.66%
QDEL
25.82
-0.59
-2.23%
RCPT
125.36
-1.73
-1.36%
RGLS
18.17
-0.4
-2.15%
RMD
64.44
-0.32
-0.49%
SCIE
0.03
0.00
0.00%
SPHS
0.68
-0.06
-8.43%
SRNE
13.25
+0.38
+2.95%
TROV
6.28
+0.23
+3.80%
VICL
0.99
+0.00
+0.01%
VOLC
17.99
0.00
0.00%
ZGNX
1.68
-0.01
-0.59%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …